• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脱氢表雄酮可抑制C57BL/KsJ-db/db小鼠肝脏中葡萄糖-6-磷酸酶mRNA水平的升高:与曲格列酮的比较。

Dehydroepiandrosterone suppresses elevated hepatic glucose-6-phosphatase mRNA level in C57BL/KsJ-db/db mice: comparison with troglitazone.

作者信息

Aoki K, Kikuchi T, Mukasa K, Ito S, Nakajima A, Satoh S, Okamura A, Sekihara H

机构信息

The Third Department of Internal Medicine, Yokohama City University School of Medicine, Japan.

出版信息

Endocr J. 2000 Dec;47(6):799-804. doi: 10.1507/endocrj.47.799.

DOI:10.1507/endocrj.47.799
PMID:11228057
Abstract

Dehydroepiandrosterone (DHEA) is known to improve hyperglycemia of diabetic C57BL/KsJ-db/db mice that are obese and insulin resistant. In a previous study, we reported that DHEA as well as troglitazone suppresses the elevated hepatic gluconeogenic enzymes, glucose-6-phosphatase (G6Pase) and fructose-1,6-bisphosphatase (FBPase) activities in C57BL/KsJ-db/db mice. In the present study, we evaluated the changes in mRNA of G6Pase and FBPase in db/db mice. Despite hyperinsulinemia, the G6Pase mRNA level of db/db mice was elevated as compared to their heterozygote littermate db/+m mice. In contrast, the FBPase mRNA level was not elevated in db/db mice. Administration of DHEA for two weeks significantly decreased the blood glucose level and the elevated G6Pase mRNA level in db/db mice. No significant changes were seen in the FBPase mRNA level after the administration of DHEA. Administration of troglitazone also decreased the blood glucose and G6Pase mRNA level in db/db mice although no changes were seen in the FBPase mRNA level. These results suggest that the elevation of G6Pase mRNA is important in elucidating the cause of insulin resistance, and that the G6Pase gene is at least one target for the hypoglycemic effects of DHEA as an insulin sensitizing agent in db/db mice.

摘要

已知脱氢表雄酮(DHEA)可改善肥胖且胰岛素抵抗的糖尿病C57BL/KsJ-db/db小鼠的高血糖症。在先前的一项研究中,我们报道DHEA以及曲格列酮可抑制C57BL/KsJ-db/db小鼠肝脏中升高的糖异生酶、葡萄糖-6-磷酸酶(G6Pase)和果糖-1,6-二磷酸酶(FBPase)的活性。在本研究中,我们评估了db/db小鼠中G6Pase和FBPase mRNA的变化。尽管存在高胰岛素血症,但与杂合子同窝出生的db/+m小鼠相比,db/db小鼠的G6Pase mRNA水平有所升高。相比之下,db/db小鼠的FBPase mRNA水平并未升高。给db/db小鼠连续两周施用DHEA可显著降低血糖水平以及升高的G6Pase mRNA水平。施用DHEA后,FBPase mRNA水平未见明显变化。施用曲格列酮也可降低db/db小鼠的血糖和G6Pase mRNA水平,尽管FBPase mRNA水平未见变化。这些结果表明,G6Pase mRNA的升高对于阐明胰岛素抵抗的原因很重要,并且G6Pase基因至少是DHEA作为db/db小鼠胰岛素增敏剂降血糖作用的一个靶点。

相似文献

1
Dehydroepiandrosterone suppresses elevated hepatic glucose-6-phosphatase mRNA level in C57BL/KsJ-db/db mice: comparison with troglitazone.脱氢表雄酮可抑制C57BL/KsJ-db/db小鼠肝脏中葡萄糖-6-磷酸酶mRNA水平的升高:与曲格列酮的比较。
Endocr J. 2000 Dec;47(6):799-804. doi: 10.1507/endocrj.47.799.
2
Dehydroepiandrosterone suppresses the elevated hepatic glucose-6-phosphatase and fructose-1,6-bisphosphatase activities in C57BL/Ksj-db/db mice: comparison with troglitazone.脱氢表雄酮可抑制C57BL/Ksj-db/db小鼠肝脏中升高的葡萄糖-6-磷酸酶和果糖-1,6-二磷酸酶活性:与曲格列酮的比较。
Diabetes. 1999 Aug;48(8):1579-85. doi: 10.2337/diabetes.48.8.1579.
3
Dehydroepiandrosterone decreases elevated hepatic glucose production in C57BL/KsJ-db/db mice.脱氢表雄酮可降低C57BL/KsJ-db/db小鼠肝脏葡萄糖生成的升高水平。
Life Sci. 2004 May 7;74(25):3075-84. doi: 10.1016/j.lfs.2003.10.031.
4
Suppression of hepatic gluconeogenesis in long-term Troglitazone treated diabetic KK and C57BL/KsJ-db/db mice.长期使用曲格列酮治疗的糖尿病KK和C57BL/KsJ-db/db小鼠肝脏糖异生的抑制作用
Metabolism. 1995 Apr;44(4):486-90. doi: 10.1016/0026-0495(95)90056-x.
5
Phosphodiesterase 3B gene expression is enhanced in the liver but reduced in the adipose tissue of obese insulin resistant db/db mouse.磷酸二酯酶3B基因在肥胖胰岛素抵抗db/db小鼠的肝脏中表达增强,但在脂肪组织中表达降低。
Diabetes Res Clin Pract. 2001 Dec;54(3):145-55. doi: 10.1016/s0168-8227(01)00271-6.
6
Troglitazone inhibits expression of the phosphoenolpyruvate carboxykinase gene by an insulin-independent mechanism.曲格列酮通过一种不依赖胰岛素的机制抑制磷酸烯醇式丙酮酸羧激酶基因的表达。
Biochim Biophys Acta. 1999 Aug 12;1451(1):122-31. doi: 10.1016/s0167-4889(99)00080-4.
7
Effects of dehydroepiandrosterone on gluconeogenic enzymes and glucose uptake in human hepatoma cell line, HepG2.脱氢表雄酮对人肝癌细胞系HepG2中糖异生酶及葡萄糖摄取的影响。
Endocr J. 2005 Dec;52(6):727-33. doi: 10.1507/endocrj.52.727.
8
Characterization of CS-045, a new oral antidiabetic agent, II. Effects on glycemic control and pancreatic islet structure at a late stage of the diabetic syndrome in C57BL/KsJ-db/db mice.新型口服抗糖尿病药物CS - 045的特性研究II. 对C57BL/KsJ - db/db小鼠糖尿病综合征晚期血糖控制及胰岛结构的影响
Metabolism. 1991 Nov;40(11):1213-8. doi: 10.1016/0026-0495(91)90218-l.
9
Effect of troglitazone, a new oral antidiabetic agent, on fructose-induced insulin resistance.新型口服抗糖尿病药物曲格列酮对果糖诱导的胰岛素抵抗的作用。
Horm Metab Res. 1995 Oct;27(10):439-41. doi: 10.1055/s-2007-979997.
10
The novel hypoglycemic agent YM440 normalizes hyperglycemia without changing body fat weight in diabetic db/db mice.新型降血糖药物YM440可使糖尿病db/db小鼠的高血糖恢复正常,且不改变体脂重量。
Metabolism. 2000 Mar;49(3):411-7. doi: 10.1016/s0026-0495(00)90440-2.

引用本文的文献

1
Low serum dehydroepiandrosterone is associated with diabetic dyslipidemia risk in males with type 2 diabetes.低血清脱氢表雄酮与 2 型糖尿病男性的糖尿病血脂异常风险相关。
Front Endocrinol (Lausanne). 2023 Nov 24;14:1272797. doi: 10.3389/fendo.2023.1272797. eCollection 2023.
2
Dehydroepiandrosterone on metabolism and the cardiovascular system in the postmenopausal period.绝经后时期脱氢表雄酮对代谢和心血管系统的影响。
J Mol Med (Berl). 2020 Jan;98(1):39-57. doi: 10.1007/s00109-019-01842-5. Epub 2019 Nov 12.
3
Sex hormones and macronutrient metabolism.
性激素与常量营养素代谢。
Crit Rev Food Sci Nutr. 2015;55(2):227-41. doi: 10.1080/10408398.2011.651177.
4
Adrenarche and middle childhood.肾上腺功能初现及其与儿童中期
Hum Nat. 2011 Sep;22(3):327-49. doi: 10.1007/s12110-011-9120-x.